W4-6 QT Interval Prolongation : Project for Database Construction, 5) Overview. Safety Margins and Integrated Risk Assessment(WORKSHOP 4: QT DATABASE CONSTRUCTION TO SUPPORT TO DEVELOP ICH-S7B GUIDELINE(SAFETY PHARMACOLOGY STUDIES TO EVALUATE QT INTERVAL
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2004-10-29
著者
関連論文
- P8-20 QT Interval Prolongation : Project for Database Construction, 14) Safety Margins of Drug-Induced QT Interval Prolongation: Comparison of Non-Clinical Animal Models and Clinical Data(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESE
- W4-6 QT Interval Prolongation : Project for Database Construction, 5) Overview. Safety Margins and Integrated Risk Assessment(WORKSHOP 4: QT DATABASE CONSTRUCTION TO SUPPORT TO DEVELOP ICH-S7B GUIDELINE(SAFETY PHARMACOLOGY STUDIES TO EVALUATE QT INTERVAL